HDAC9 and neoplasm: These observations suggest a possible ‘differentiation’ effect of this combination and we hypothesise that tumour marker increases may represent a potential signal for drug exposure, as was shown with another HDAC inhibitor, phenylbutyrate (Gilbert et al, 2001).